CommentInterstitial lung diseases: quo vadis?
References (13)
- et al.
Interstitial lung disease in 2020: a history of progress
Clin Chest Med
(2021) - et al.
Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities
Lancet Respir Med
(2021) - et al.
Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society
Lancet Respir Med
(2020) - et al.
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities
Lancet Respir Med
(2020) - et al.
Patients with IPF and lung cancer: diagnosis and management
Lancet Respir Med
(2018) - et al.
Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia?
Lancet
(2021)
There are more references available in the full text version of this article.
Cited by (3)
Interstitial lung diseases—Intersectoral modern diagnostics and treatment
2024, Zeitschrift fur PneumologieComparing outcomes of ILD patients managed in specialised versus non-specialised centres
2022, Respiratory ResearchDevelopment and progress in interstitial lung diseases
2022, Pneumologe
© 2021 Elsevier Ltd. All rights reserved.